Elif Tuğçe Korkmaz

Elif Tuğçe Korkmaz

Auto-generated profile, based on publicly available information

Elif Tuğçe Korkmaz

Division of Immunology and Allergy, Faculty of Medicine, Ankara University; Ankara-Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2021 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
ASAbdulsamet Sandal
Abdulsamet Sandal
EKElif Tuğçe Korkmaz
Elif Tuğçe Korkmaz
FAFunda Aksu
Funda Aksu
DKDeniz Köksal
Deniz Köksal
ZSZiya Toros Selçuk
Ziya Toros Selçuk
LÇLütfi Çöplü
Lütfi Çöplü
In this study, we aimed to evaluate the accuracy of the original and simplified pulmonary embolism (PE) severity index (PESI) to predict all-cause mortality after 30 days of acute PE diagnosis up to five years within consecutive sub-periods. Adult patients diagnosed with acute PE between January 1, 2003, and June 30, 2013, were retrospectively included. Data on baseline characteristics and mortality during a five-year follow-up were collected. The study included 414 patients (Male/Female=192/222). The median age at diagnosis was 61.5 (minimum–maximum, 18–93) years. Mortality rates were 13.3% at 30 days, 21.8% at 90 days, 32.6% at one year, and 51.0% at five years. Both stratification into risk classes according to the original PESI and low vs. high-risk classification of original and simplified PESI were significantly correlated with the 30-day, 31–90-day, 91-day-one-year, and one-five-year mortality. Significant PESI predictors for mortality were history of cancer [hazard ratio (HR): 3.31, 95% confidence interval (CI): 1.64–6.68; p=0.001] and heart failure (HR: 2.35, 95% CI: 1.04–5.32, p=0.041) at 31–90-day, history of cancer (HR: 5.45, 95% CI: 2.86–10.40, p<0.001) at 91-day-one-year, advancing age (HR: 1.04, 95% CI: 1.02–1.06, p<0.001) and history of cancer (HR: 5.53, 95% CI: 3.41–8.98, p<0.001) at one-five-year after acute PE diagnosis. All-cause long-term mortality in high-risk patients with acute PE according to original or simplified PESI significantly increased up to five years of follow-up. This survival disadvantage was mainly related to cancer and comorbidities rather than acute clinical manifestations. Future prospective studies are needed to demonstrate the effect of various comorbidities on long-term mortality in these patients.